Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

Int J Dermatol. 2007 Jan;46(1):94-8. doi: 10.1111/j.1365-4632.2006.03079.x.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Double-Blind Method
  • Eflornithine / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Face*
  • Female
  • Hair / drug effects*
  • Hirsutism / drug therapy*
  • Humans
  • Middle Aged
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Eflornithine